About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

CRISPR-Cas9 Gene Editing Tool Helps in Making Blood Transfusions Safe

by Rishika Gupta on April 28, 2018 at 12:50 PM
Font : A-A+

CRISPR-Cas9 Gene Editing Tool Helps in Making Blood Transfusions Safe

Blood transfusions can be made safe by decreasing reactive immune responses caused by frequent transfusions. This is very helpful in patients who have thalassemia or sickle cell disease and those who require regular blood transfusions. Immune responses can be decreased by CRISPR-Cas9 gene editing tool. The finding of this study is published in the Journal of EMBO Molecular Medicine.

While most people can safely receive a blood transfusion from donated blood, patients with blood disorders such as thalassemia or sickle cell disease require frequent transfusions. With repeated transfusion, patients eventually develop an immune response to all but the most specifically matched donor blood due to incompatibility at the level of minor blood group antigens.

Advertisement


Using CRISPR-Cas9 mediated gene editing, the team of scientists based at the NIHR Blood and Transplant Research Unit (NIHR BTRU) in red cell products, BrisSynBio Centre and NHS Blood and Transplant in Bristol created individual cell lines in which specific blood group genes were altered to prevent the expression of blood group proteins that can cause immune reactions.

Building on this gene-editing approach, the team then went on to produce cells that combined the deletion of multiple blood groups in a single cell line that could be differentiated to generate functional novel red blood cells with extremely broad transfusion compatibility. Transfusions of red blood cells edited to improve compatibility could provide better treatments for those patients whose clinical needs are difficult to meet.
Advertisement

This study, published this week in the prestigious EMBO Molecular Medicine journal provides the first proof of principle demonstration that gene editing can be used in combination with laboratory culture of red blood cells to generate rare or customized red blood cells for patients with specific needs. While the authors are keen to stress the many challenging technical obstacles that must be overcome before this approach could be translated to a clinical product, the work does provide an exciting window into the possible applications of red blood cells produced from gene edited cell lines.

Dr. Ashley Toye Director of the Bristol NIHR BTRU said: "Blood made using genetically edited cells could one day provide compatible transfusions for a group of patients for whom blood matching is difficult or impossible to achieve within the donor population. However, much more work will still be needed to produce blood cells suitable for patient use."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
First-Ever Successful Pig-To-Human Kidney Transplantation
World Osteoporosis Day 2021 -
Spirituality and Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Thalassemia Weaver Syndrome Thrombocytopenia Blood in Stools - Symptom Evaluation Bombay Blood Group CRISPR 

Recommended Reading
Prehospital Blood Transfusion Linked With Improved Survival
Blood product transfusion within minutes of injury or prior to hospitalization is associated with .....
Blood Transfusion From Previously Pregnant Donor Increases Mortality Risk
Transfusion-related acute lung injury occurs mainly due to transfusions from female donors with a .....
Reports Investigated 10 Percent Increase In The Number Of HIV Cases Through Blood Transfusion
One out of 100 HIV patients are tested positive for the virus who were found to be contracting the ....
Nearly 2,000 Indians Contract HIV After Receiving Blood Transfusions
Access to safe blood is limited, especially in rural areas, because of a lack of proper screening .....
Blood in Stools - Symptom Evaluation
Blood in stools results from bleeding that arises from any part of the digestive tract. Causes of bl...
Bombay Blood Group
Bombay blood group is a rare blood type in which the people have an H antigen deficiency. They can r...
CRISPR
CRISPR is a gene editing tool that is revolutionizing medical care with prospective cure for genetic...
DNA Finger Printing
DNA fingerprinting is a technique which helps forensic scientists and legal experts solve crimes, id...
Thalassemia
Thalassemia is an inherited blood disorder passed on through parental genes causing the body to prod...
Thrombocytopenia
Thrombocytopenia or low platelet count develops when platelet levels fall below normal range caused ...
Weaver Syndrome
Weaver syndrome is a genetic disorder in which children show accelerated bone growth, advanced bone ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use